Phaseline

Targets › HIST1H3A

HIST1H3A: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Respiratory; next expected readout Jan 2027.

Open in Phaseline: the race on HIST1H3A, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
HTICHT31-1
humanized monoclonal antibody against citrullinated histone H3
HIST1H3APhase 1ARDS (Acute Respiratory Distress Syndrome)Jan 2027

Conditions

ARDS (Acute Respiratory Distress Syndrome) (1)

Modalities

antibody (1)

Companies

HTIC (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.